摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物 | 2642-43-5

中文名称
胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物
中文别名
胸酰嘧啶-3-磷酸
英文名称
thymidine 3'-monophosphate
英文别名
3'-thymidine monophosphate;[(2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl] dihydrogen phosphate
胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物化学式
CAS
2642-43-5
化学式
C10H15N2O8P
mdl
——
分子量
322.211
InChiKey
XXYIANZGUOSQHY-XLPZGREQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.69±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -2.4
  • 重原子数:
    21
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    146
  • 氢给体数:
    4
  • 氢受体数:
    8

SDS

SDS:424d03ad962c9dcac4bf41d07ee02cff
查看
Version 1.4
Regulation (EC) No 1907/2006

1 - Product and Company Information

Product Name THYMIDINE 3'-MONOPHOSPHATE AMMONIUM
SALT HYDRATE

2 - Hazards Identification

3 - Composition/Information on Ingredients

Product Name CAS # EC no Annex I
Index Number
THYMIDINE 3'-MONOPHOSPHATE None None None
AMMONIUM SALT HYDRATE
Formula C10H14N2O8P · xNH3 · yH2O
Molecular Weight 321,2000 AMU

4 - First Aid Measures

5 - Fire Fighting Measures

6 - Accidental Release Measures

7 - Handling and Storage

STORAGE
Store at -20°C

8 - Exposure Controls / Personal Protection

9 - Physical and Chemical Properties

pH N/A
BP/BP Range N/A
MP/MP Range N/A
SIGMA www.molbase.com
Flash Point N/A
Flammability N/A
Autoignition Temp N/A
Oxidizing Properties N/A
Explosive Properties N/A
Explosion Limits N/A
Vapor Pressure N/A
Partition Coefficient N/A
Viscosity N/A
Vapor Density N/A
Saturated Vapor Conc. N/A
Evaporation Rate N/A
Bulk Density N/A
Decomposition Temp. N/A
Solvent Content N/A
Water Content N/A
Surface Tension N/A
Conductivity N/A
Miscellaneous Data N/A
Solubility N/A

10 - Stability and Reactivity

11 - Toxicological Information

12 - Ecological Information

No data available.

13 - Disposal Considerations

14 - Transport Information

RID/ADR
Non-hazardous for road transport.
IMDG
Non-hazardous for sea transport.
IATA
Non-hazardous for air transport.

15 - Regulatory Information

Caution: Substance not yet fully tested (EU).
COUNTRY SPECIFIC INFORMATION
Germany
WGK: 3
Self-Classification

16 - Other Information

WARRANTY
The above information is believed to be correct but does not
purport to be all inclusive and shall be used only as a guide. The
SIGMA www.molbase.com
information in this document is based on the present state of our
knowledge and is applicable to the product with regard to
appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Inc.,
shall not be held liable for any damage resulting from handling or
from contact with the above product. See reverse side of invoice
or packing slip for additional terms and conditions of sale.
Copyright 2010 Co. License granted to make
unlimitedpaper copies for internal use only.
DISCLAIMER
For R&D use only. Not for drug, household or other uses.
SIGMA www.molbase.com


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物 在 cerium(III) chloride 、 HEPES buffer 、 氧气 作用下, 以 为溶剂, 生成 beta-胸苷
    参考文献:
    名称:
    Hydrolysis of phosphomonoesters in nucleotides by cerium(IV) ions. Highly selective hydrolysis of monoester over diester in concentrated buffers
    摘要:
    在生理条件下,核苷酸中的磷酸单酯可被 CeIV 离子有效水解。在 pH 值为 7.2、温度为 50 °C 的条件下([CeIV] = 10 mM),残基的半衰期约为 10 分钟。CeIV 离子水解磷酸单酯的速度快于水解磷酸二酯的速度。值得注意的是,使用浓缩缓冲溶液(TRIS 和 HEPES)可显著提高单酯水解对二酯水解的选择性。在 500 mM TRIS 缓冲溶液中,pdA 和 dAp 的水解速度分别是 d(ApA) 的 500 倍和 580 倍,而在 50 mM TRIS 缓冲溶液中的相应比率分别为 85 倍和 90 倍。在这些浓缩缓冲液中,CeIV 可以选择性地去除 d(pApA)的末端单磷酸。
    DOI:
    10.1039/a701481c
  • 作为产物:
    描述:
    保护胸苷sodium hydroxide 、 TPS-TAZ 、 溶剂黄146 作用下, 以 吡啶乙醇 为溶剂, 反应 2.83h, 生成 胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物
    参考文献:
    名称:
    核苷磷酸化的新方法
    摘要:
    开发了一种新的磷酸化试剂2- O-(4,4'-二甲氧基三苯甲基)乙基磺酰lethan-2'-基磷酸酯(1),用于磷酸化核苷的伯醇和仲醇。在许多研究的实例中,磷酸化步骤的收率非常好(约80%至95%)。该方法不仅在核苷和核苷酸化学中,而且在诸如碳水化合物和氨基酸的生物分子的磷酸化中都有广泛的应用潜力。
    DOI:
    10.1016/s0040-4039(00)01251-x
点击查看最新优质反应信息

文献信息

  • The synthesis of di- and oligo-nucleotides containing a phosphorodithioate internucleotide linkage with one of the sulfur atoms in a 5′-bridging position
    作者:Magdalena Olesiak、Wojciech J. Stec、Andrzej Okruszek
    DOI:10.1039/b901791g
    日期:——
    phosphorodithioate linkage is described, wherein one of the sulfur atoms occupies a 5′-bridging position. Representative dinucleotides possessing such a bond were synthesized by S-alkylation of nucleoside-3′-O-phosphorodithioates with 5′-halogeno-5′-deoxy-nucleosides. A fully protected dithymidylate containing internucleotide 5′-S-phosphorodithioate linkage was converted into a 3′-O-phosphoramidite
    描述了一种新型的核苷酸间二硫代磷酸酯键,其中一个原子占据5'-桥接位置。具有这种键的代表性二核苷酸是通过将核苷-3'- O-二硫代磷酸酯与5'-卤素-5'-脱氧核苷进行S-烷基化而合成的。将含有核苷酸间5'- S-二硫代磷酸酯键的完全保护的二胸苷酸转化为3'- O-亚酰胺衍生物,并用于将修饰的二核苷酸引入寡核苷酸序列的预定位置。5'- S发现二核苷酸类似物中的β-二硫代磷酸酯键抗蛇毒PDE和核酸酶P1的核酸降解。然而,在小牛脾PDE处理下,观察到5'- S-二硫代磷酸代二胸苷类似物的非对映异构体的P-立体选择性降解。在的存在下溶液容易降解新的5'- S-磷酸酯键。。还发现含有单个5'- S-磷酸酯键的寡胸苷酸酯与其互补序列形成弱得多的双链体。
  • SYNTHESIS OF NUCLEOSIDE PHOSPHOTRIESTERS CONTAINING AMIDATE OR THIOATE FUNCTIONS
    作者:Stan A. A. van Boeckel、Gijs van der Marel、Gerry Wille、Jacq H. van Boom
    DOI:10.1246/cl.1981.1725
    日期:1981.12.5
    Phosphorylation of properly protected nucleosides with aryl or alkyl phosphorodichloridates, in the presence of 1-hydroxybenzotriazole, gives phosphorylated intermediates which react smoothly with different amine or thiol functions to afford the corresponding amidate or thioate phosphotriester derivatives.
    1-羟基苯并三唑的存在下,用芳基或烷基二磷酸酯对适当保护的核苷进行磷酸化,得到磷酸化的中间体,该中间体与不同的胺或醇官能团顺利反应,得到相应的酰胺或硫代磷酸三酯衍生物
  • Oligonucleotides and nucleotidopeptides. XLII. Efficacy of the intramolecular influence of the carboxy groups of amino acids in nucleotidyl-(P → N)-amino acids (peptides) as a function of their positions
    作者:B. A. Yuodka、L. E. Lioranchaite、V. R. Baltenas
    DOI:10.1007/bf00579428
    日期:1982.11
    has been established that remote carboxy groups in nucleotidyl-(5′ → N)-β-alanine and -alanylalanine do not affect the mechanism of the cleavage of the phosphoramide center. The situation is different in the case of nucleotidyl-(5′ → Nɛ)-lysine. It has been shown that in the 3′-phenylalanine derivative of dTMP, the influence of the α-carboxy group of the amino acid is only half as great as in the 5′-analog
    已经确定核苷酸基-(5' → N)-β-丙氨酸和-丙酸丙酸中的远程羧基不影响酰胺中心裂解的机制。核苷酸-(5′ → Nɛ)-赖酸的情况有所不同。已经表明,在 dTMP 的 3'-苯丙酸衍生物中,氨基酸的 α-羧基的影响仅为 5'-类似物的一半。寡核苷酸基-(Pin → N)-氨基酸氨基酸的α-羧基也削弱了酰胺中心裂解的机制。
  • A general approach to nucleoside 3′- and 5′- monophosphates
    作者:Y. Hayakawa、S. Wakabayashi、T. Nobori、R. Noyori
    DOI:10.1016/s0040-4039(00)96095-7
    日期:1987.1
    Diallyloxyphosphorylation of nucleoside hydroxyls followed by palladium(0)-catalyzed deallylation provides a new, general method for the preparation of the 3′- and 5′-monophosphates.
    核苷羟基的二烯丙氧基磷酸化反应,再由(0)催化的脱醛反应,为制备3'-和5'-单磷酸酯提供了一种新的通用方法。
  • Precolumn Derivatization of Nucleotides Based on Fluorescent Carbamate Formation on the Sugar Moieties in High-Performance Liquid Chromatography.
    作者:Hiroaki NAGAOKA、Hitoshi NOHTA、Mikihiko SAITO、Yosuke OHKURA
    DOI:10.1248/cpb.40.2559
    日期:——
    The fluorescence derivatization of nucleotides with 2-(5-chlorocarbonyl-2-oxazolyl)5, 6-methylenedioxybenzo-furan in the presence of sodium azide and the separation of the derivatives by high-performance liquid chromatography are described. The reagent reacts with 5'-terminal hydroxyl groups of nucleotides to produce the correspoding fluorescent carbamates. The derivatives of mono- and oligonucleotides are separated by chromatography on a reversed phase column (TSKgel ODS-80TM) and the derivatices of octa- and deca-nucletides on a size exclusion column (TSKgel G3000SWXL). The detection limits (signal-to-noise ratio-3) are 0.8-6.0 pmol on column. 5'-Phosphorylated nucleotide also gives a fluorescent derivative after alkaline phosphatase-mediated dephosphorylation.
    描述了核苷酸与2-(5-碳酰基-2-噁唑基)5,6-亚甲基二氧苯并呋喃在存在叠氮的条件下进行荧光衍生化,并通过高效液相色谱分离衍生物。该试剂与核苷酸的5'末端羟基反应,生成相应的荧光氨基甲酸酯。单核苷酸和寡核苷酸的衍生物通过反相色谱柱(TSKgel ODS-80TM)分离,而八核苷酸和十核苷酸的衍生物则在尺寸排阻柱(TSKgel G3000SWXL)上分离。检测限(信噪比3)为0.8-6.0 pmol。在碱性磷酸酶介导的脱磷酸化后,5'-磷酸化核苷酸也会生成荧光衍生物
查看更多

同类化合物

腺苷-3’-磷酸 胸苷酰-(3'-5')-胸苷氰基乙基磷酰三酯 胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物 胞啶-3'-单磷酸二钠盐 环(腺苷酰(3'-5')尿苷单磷酸酯) 尿苷酸 尿苷溴乙酰甲醇5'-二磷酸酯 尿苷氯乙酰甲醇5'-二磷酸酯 丁二酸,甲基-,1-(苯基甲基)酯,(2R)-(9CI) [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]苯基磷酸氢酯 [(2R,3S,4R,5R)-5-(2-氨基-6-氧代-3H-嘌呤-9-基)-2-[(2-甲酰基苯氧基)甲基]-4-羟基四氢呋喃-3-基]磷酸二氢酯 N-苯甲酰基-2'-脱氧-3'-胞苷酸2-氯苯基2-氰基乙基酯 8-[(E)-苄亚基氨基]-2'-脱氧腺苷3'-(磷酸二氢酯) 5-甲基-2'-脱氧胞苷-3'-磷酸 3'-(二氢磷酸)鸟嘌呤核苷 3'-(1-丁基磷酰)腺苷 2ˊ-脱氧胞苷-3ˊ-一磷酸 2-脱氧腺苷-3-单磷酸酯*铵 2'-脱氧鸟苷 3'-(磷酸二氢酯) 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷酰-(3'-5)-2'-脱氧腺苷 2'-脱氧-3'-胞苷酸二钠盐 2' -脱氧3' -磷酸游离酸 [3']thymidylic acid mono-[4-(2-iodo-acetylamino)-phenyl] ester 5-Fluor-1-β-D-arabinofuranosylcytosin-3'-phosphat [3']thymidylic acid mono-[4-(2-bromo-acetylamino)-phenyl] ester O2'-Methylguanosin-3'-phosphorsaeure uridine-3'-(2-cyanoethyl)phosphate [3']thymidylic acid mono-[4-(2-chloro-acetylamino)-phenyl] ester (1R)-1-(6-amino-purin-9-yl)-O3-phosphono-1,5-anhydro-D-glucitol Thymidin-3'-(2,4-dinitrophenyl)phosphat N4-Dimethylamino-methylen-2',5'-bis-O-(1-ethoxy-ethyl)-cytidin-3'-phosphat (2R)-3-((hydroxy(((2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)oxy)phosphoryl)oxy)propane-1,2-diyl dioleate 3-Methyl-uridin-3'-phosphat 2'-O-(tert-butyldimethylsilyl)inosine 3'-(allyl 2-cyanoethylphosphate) 2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-(2-chlorophenoxy)phosphoryl-2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-(2-chlorophenoxy)phosphoryl-2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-(2-chlorophenoxy)phosphoryl-2'-O-(2-tetrahydrofuranyl)-N4-(4-anisoyl)cytidine-3'-[O-(2-cyanoethyl)(2-chlorophenyl)phosphate] Phosphoric acid mono-[(2S,5R)-5-(2,4-diamino-pyrrolo[2,3-d]pyrimidin-7-yl)-2,5-dihydro-furan-2-ylmethyl] ester; compound with triethyl-amine 9-β.D-Glucopyranosyl-adenin-4'-phosphat 4-Oxo-pentanoic acid (2R,3S,5R)-3-[(2-chloro-phenoxy)-hydroxy-phosphoryloxy]-5-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester N(4),O(2')-Dibenzoyl-cytidin-3'-phosphat cis-((5-((4-amino-2-oxopyrimidin-1(2H)-yl)methyl)-1,3-oxathiolan-2-yl)methyl) (2R,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl hydrogen phosphate 1,20-(icosanedioxy)bis-(3'-phosphatidyl-2'-deoxythymidine) 4-N-benzoyl-5'-O-[di(2-cyanoethyloxy)phosphoryl]-2'-deoxycytidylyl-{3'-OP-(2-cyanoethyl)->5'}-6-N-benzoyl-2',3'-di-O-(tert-butyldimethylsilyl)adenosine [3']uridylic acid mono-[1-(5,6-bis-ethoxycarbonylamino-pyrimidin-4-ylamino)-β-D-1-deoxy-ribofuranos-5-yl] ester 1-β-D-Arabinofuranosylcytidin-3'-phosphat OH[AA]AZMB